VIALE-A Extended Follow-up
VIALE-A: Extended Follow-up of Azacitidine ± Venetoclax in Patients With Treatment-Naive AML Ineligible for Standard Induction Chemotherapy

Released: December 17, 2022

Expiration: December 16, 2023

Activity

Progress
1
Course Completed